SPY357.46+2.13 0.60%
DIA295.89+3.36 1.15%
IXIC11,880.63+25.66 0.22%

Opiant Pharmaceuticals Q3 EPS $0.15 Beats $(0.21) Estimate, Sales $9.11M Beat $7.76M Estimate

Opiant Pharmaceuticals (NASDAQ:OPNT) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $(0.21) by 171.43 percent. This is a 92.39 percent decrease over earnings of $1.97 per

· 11/12/2020 16:15
Opiant Pharmaceuticals (NASDAQ:OPNT) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $(0.21) by 171.43 percent. This is a 92.39 percent decrease over earnings of $1.97 per share from the same period last year. The company reported quarterly sales of $9.11 million which beat the analyst consensus estimate of $7.76 million by 17.35 percent. This is a 55.88 percent decrease over sales of $20.64 million the same period last year.